INA significant development in DNA vaccination research, India's first and only DNA vaccine candidate for dengue has shown promising results. In preliminary trials on mice, the candidate generated a robust immune response and improved survival rates after exposure to the disease.
The DNA vaccine candidate has been in development since 2019 by scientists from the National Centre for Biological Sciences (NCBS), Bengaluru, in collaboration with nine institutions in India, Africa and the US. The team at NCBS is led by Sudhir Krishna, a professor specialising in biochemistry. While his laboratory primarily works on human cervical cancer research, the team became interested in dengue vaccination in 2011 after collaborating with St John's Medical College, Bengaluru, to sequence samples collected from dengue patients. "We need a dengue vaccine because it is a major public health burden in India," says Arun Sankara-doss, research lead of the dengue vaccine programme at NCBS. In 2021, India reported 110,473 dengue cases, ranking fourth among the worst-affected nations.
The team chose DNA technology since it is considered stable, cost-effective and safer than whole-virus vaccines. "Traditional vaccines essentially contain the whole virus. But we speculate some regions in the virus could be responsible for adverse effects," says Swetha Raghavan, a postdoctoral researcher at NCBS. A DNA platform, she explains, allows researchers to pick certain regions that can provoke an effective response and eliminate those likely to cause harm. Further, this vaccine can be modified to target other viruses.
This story is from the February 16, 2023 edition of Down To Earth.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the February 16, 2023 edition of Down To Earth.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
In leading role again
MOVIES AND WEB SERIES ARE ONCE AGAIN BEING SET IN RUSTIC BACKGROUNDS, INDICATING A RECONNECT BETWEEN CINEMA AND THE COUNTRYSIDE
One Nation One Subscription comes at a huge cost
As top US universities scrap big deals with top scientific publishers, India’s ONOS scheme seems flawed and outdated
Return of Rambhog
Bid to revive and sell the aromatic indigenous paddy variety has led to substantial profits for farmers in Uttar Pradesh's Terai region
Scarred by mining
Natural springs of Kashmir drying up due to illegal riverbed mining
Human-to-human spread a mutation away
CANADA IN mid-November confirmed its first human case of avian influenza, with a teenager in the British Columbia being hospitalised after contracting the H5N1 virus that causes the disease. The patient developed a severe form of the disease, also called bird flu, and had respiratory issues. There was no known cause of transmission.
True rehabilitation
Residents of Madhya Pradesh's Kakdi village take relocation as an opportunity to undertake afforestation, develop sustainable practices
INESCAPABLE THREAT
Chemical pollution is the most underrated and underreported risk of the 21st century that threatens all species and regions
THAT NIGHT, 40 YEARS AGO
Bhopal gas disaster is a tragedy that people continue to face
A JOKE, INDEED
A CONFERENCE OF IRRESPONSIBLE PARTIES THAT CREATED AN OPTICAL ILLUSION TO THE REALITY OF A NEW CLIMATE
THINGS FALL APART
THE WORLD HAS MADE PROGRESS IN MITIGATING EMISSIONS AND ADAPTING TO CLIMATE IMPACTS. BUT THE PROGRESS REMAINS GROSSLY INADEQUATE
